Ventas, Inc. $VTR Shares Purchased by Cibc World Market Inc.

Cibc World Market Inc. raised its position in Ventas, Inc. (NYSE:VTR) by 49.0% during the third quarter, HoldingsChannel.com reports. The firm owned 269,789 shares of the real estate investment trust’s stock after buying an additional 88,738 shares during the quarter. Cibc World Market Inc.’s holdings in Ventas were worth $18,883,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Vanguard Group Inc. increased its position in Ventas by 4.1% during the 2nd quarter. Vanguard Group Inc. now owns 71,796,312 shares of the real estate investment trust’s stock worth $4,533,937,000 after purchasing an additional 2,854,751 shares in the last quarter. State Street Corp increased its position in shares of Ventas by 5.2% in the second quarter. State Street Corp now owns 27,998,629 shares of the real estate investment trust’s stock worth $1,781,267,000 after acquiring an additional 1,388,678 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of Ventas by 4.9% in the 2nd quarter. Geode Capital Management LLC now owns 12,226,283 shares of the real estate investment trust’s stock valued at $769,061,000 after acquiring an additional 574,663 shares during the period. Charles Schwab Investment Management Inc. lifted its holdings in shares of Ventas by 6.3% during the 2nd quarter. Charles Schwab Investment Management Inc. now owns 5,597,778 shares of the real estate investment trust’s stock valued at $353,500,000 after acquiring an additional 331,477 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA boosted its position in Ventas by 1.0% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 5,570,471 shares of the real estate investment trust’s stock worth $351,775,000 after purchasing an additional 53,614 shares during the period. 94.18% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

VTR has been the topic of several recent analyst reports. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $100.00 price target on shares of Ventas in a report on Monday. Wells Fargo & Company boosted their price objective on Ventas from $80.00 to $88.00 and gave the company an “overweight” rating in a research report on Tuesday, November 25th. Royal Bank Of Canada raised their target price on Ventas from $83.00 to $91.00 and gave the company an “outperform” rating in a research note on Tuesday. KeyCorp lifted their price objective on shares of Ventas from $85.00 to $90.00 and gave the company an “overweight” rating in a research report on Tuesday. Finally, Citigroup lifted their price target on Ventas from $88.00 to $96.00 and gave the company a “buy” rating in a report on Wednesday. Fourteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $85.38.

Ventas Trading Down 0.5%

VTR stock opened at $85.26 on Friday. The company has a quick ratio of 0.32, a current ratio of 0.67 and a debt-to-equity ratio of 1.03. Ventas, Inc. has a twelve month low of $60.08 and a twelve month high of $87.20. The company has a market cap of $40.50 billion, a P/E ratio of 157.89, a PEG ratio of 2.09 and a beta of 0.77. The business has a fifty day moving average of $78.45 and a 200-day moving average of $73.68.

Ventas (NYSE:VTR) last announced its quarterly earnings results on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.89 by ($0.74). The business had revenue of ($1,229.71) million during the quarter, compared to the consensus estimate of $1.53 billion. Ventas had a return on equity of 2.09% and a net margin of 4.31%.The firm’s revenue was up 21.7% compared to the same quarter last year. During the same quarter last year, the company earned $0.81 earnings per share. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. As a group, equities research analysts expect that Ventas, Inc. will post 3.4 EPS for the current year.

Ventas Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, April 16th. Stockholders of record on Tuesday, March 31st will be given a $0.52 dividend. The ex-dividend date of this dividend is Tuesday, March 31st. This is a boost from Ventas’s previous quarterly dividend of $0.48. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.4%. Ventas’s dividend payout ratio (DPR) is presently 355.56%.

Insider Transactions at Ventas

In other Ventas news, CEO Debra A. Cafaro sold 41,294 shares of Ventas stock in a transaction on Monday, November 17th. The stock was sold at an average price of $79.01, for a total value of $3,262,638.94. Following the completion of the transaction, the chief executive officer directly owned 1,145,695 shares of the company’s stock, valued at $90,521,361.95. The trade was a 3.48% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Peter J. Bulgarelli sold 2,771 shares of the company’s stock in a transaction on Tuesday, November 18th. The stock was sold at an average price of $80.01, for a total value of $221,707.71. Following the sale, the chief executive officer owned 108,717 shares of the company’s stock, valued at $8,698,447.17. The trade was a 2.49% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 96,868 shares of company stock valued at $7,574,022. 0.80% of the stock is currently owned by company insiders.

Ventas Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.